Shares Magazine
16.30p-0.70 (-4.12%)07 Mar 2025, 14:06
Jump to:
Sareum Holdings PLC Fundamentals
| Company Name | Sareum Holdings PLC | Last Updated | 2025-03-07 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 124.928 m | Market Cap | £20.36 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.04 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | 1.3089 | Cash Equity Ratio | 0.6902 |
| Quick Ratio | 2.3538 | Current Ratio | 4.22 |
| Price To Book Value | 10.0503 | ROCE | 0 |
Sareum Holdings PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Sareum Holdings PLC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|---|---|---|
| Tangible Assets | 0 | £1,000.00 | £2,000.00 |
| Intangible Assets | 0 | 0 | 0 |
| Investments | £9,000.00 | £46,000.00 | £23,000.00 |
| Total Fixed Assets | £9,000.00 | £47,000.00 | £25,000.00 |
| Stocks | 0 | 0 | 0 |
| Debtors | £78,000.00 | £81,000.00 | £45,000.00 |
| Cash & Equivalents | £1.46 m | £994,000.00 | £4.26 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £2.77 m | £2.02 m | £4.79 m |
| Liabilities | 2024 | 2023 | 2022 |
|---|---|---|---|
| Creditors within 1 year | £653,000.00 | £867,000.00 | £455,000.00 |
| Creditors after 1 year | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £653,000.00 | £867,000.00 | £455,000.00 |
| Net assets | £2.11 m | £1.15 m | £4.33 m |
| Equity | 2024 | 2023 | 2022 |
|---|---|---|---|
| Called up share capital | £1.35 m | £851,000.00 | £851,000.00 |
| Share Premium | £24.80 m | £20.93 m | £20.93 m |
| Profit / Loss | -£4.60 m | -£4.03 m | -£2.58 m |
| Other Equity | £2.11 m | £1.15 m | £4.33 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | £2.11 m | £1.15 m | £4.33 m |
| Ratios | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 |
| Debt-to-Equity | 0 | 0 | 0 |
| Assets / Equity | 1.3089 | 1.3089 | 1.3089 |
| Cash / Equity | 0.6902 | 0.6902 | 0.6902 |
| EPS | -£0.04 | -£0.05 | -£0.03 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash from operating activities | -£3.92 m | -£3.27 m | -£2.13 m |
| Cashflow before financing | £456,000.00 | -£3.27 m | £1.58 m |
| Increase in Cash | £465,000.00 | -£3.27 m | £1.57 m |
| Income | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | 0 | 0 | 0 |
| Cost of sales | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Profit | -£4.63 m | -£4.07 m | -£2.58 m |
| Pre-Tax profit | -£4.60 m | -£4.03 m | -£2.58 m |
Sareum Holdings PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others. |
| Latest Interim Date | 28 Mar 2025 |
| Latest Fiscal Year End Date | 29 Oct 2024 |
Sareum Holdings PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2024-12-20 | Dr. Timothy John Mitchell | Executive Director,Chief Operating Officer |
| 2024-12-20 | Dr. John Charles Reader | Executive Director,Chief Scientific Officer |
| 2016-03-14 | Dr. Paul Bernard Harper | Non-Executive Director,Chairman |
| 2007-11-19 | Dr. Alastair James Riddell | Non-Executive Director |
| 2006-06-30 | Mr. Edward Morgan Oliver FCA | Executive Director,Finance Director |
| 2007-06-30 | Dr. David Hugh Williams, B.Sc. ,PhD | Executive Director,VP of Biology and Structural Sciences |
| 2006-06-30 | Dr. Alan Gordon Lamont, PhD | Non-Executive Director |
| 2007-10-26 | Mr. Ernesto Giorgio Reggiani MBA,ACMA,BComm | Executive Director,Finance Director and Company Secretary |
| 2024-12-20 | Dr. Stephen Barry Parker | Executive Director,Chairman |
| 2024-11-27 | Dr. Michael John Owen | Non-Executive Director |
| 2024-11-27 | Mr. Clive Birch | Non-Executive Director,Senior Independent Director |
Sareum Holdings PLC Contact Details
| Company Name | Sareum Holdings PLC |
|---|---|
| Address | Langford Arch, London Road, Unit 2A, Pampisford, Cambridge, CB22 3FX |
| Telephone | +44 1223497700 |
| Website | http://www.sareum.com |
Sareum Holdings PLC Advisors
| Nominated Adviser | WH Ireland Limited |
|---|---|
| Phone | +44 2072201666 |
| Fax | +44 2072201667 |
| Stockbroker | WH Ireland Ltd |
|---|---|
| Phone | +44 2072201666 |
| Fax | +44 2072201667 |
| Auditor | Shipleys LLP |
|---|---|
| Phone | +44 2073120000 |
| Fax | +44 2073120022 |
| Registrar | Capita Asset Services |
|---|---|
| Phone | +44 8716640300 |
| Fax | +44 2086392342 |
| Stockbroker | Hybridan LLP |
|---|---|
| Phone | +44 203764 2341 |
| Fax | +44 2076001586 |
| Financial PR Adviser | Communications Portfolio (The) |
|---|
| Solicitor | Taylor Vinters |
|---|---|
| Phone | +44 1223423444 |
| Fax | +44 1223423486 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Oxford Nanopore Technologies PLC | 100.40 | 8.07 |
| Metro Bank Holdings PLC | 88.10 | 4.14 |
| Hunting PLC | 295.00 | 2.97 |
| Taylor Wimpey PLC | 113.66 | 3.14 |
| Greggs PLC | 1,809.22 | 2.68 |
| Barratt Redrow PLC | 428.40 | 3.08 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Just Group PLC | 150.40 | -7.84 |
| Burberry Group PLC | 995.20 | -6.99 |
| Melrose Industries PLC | 517.12 | -7.06 |
| Spire Healthcare Group PLC | 177.40 | -5.94 |
| Schroders PLC | 406.60 | -5.04 |
| Anglo American PLC | 2,349.50 | -4.59 |